Clinical Trial Update: 24-hour Control of Intraocular Pressure (IOP) in Ocular Hypertension [Phase 4]

View source ↗

Summary

Phase 4 clinical trial conducted by the University of Parma evaluating 24-hour intraocular pressure control in ocular hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension

Snippet

Sponsor: University of Parma | Conditions: Ocular Hypertension | Phase 4 | Status: COMPLETED